• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞自主和非自主过程都调节复制时间和突变率之间的关联。

Both cell autonomous and non-autonomous processes modulate the association between replication timing and mutation rate.

机构信息

Department of Microbiology and Molecular Genetics, IMRIC, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Sharett Institute for Oncology, The Gaffin Center for Neuro-Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.

出版信息

Sci Rep. 2023 Aug 12;13(1):13143. doi: 10.1038/s41598-023-39463-1.

DOI:10.1038/s41598-023-39463-1
PMID:37573368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10423235/
Abstract

Cancer somatic mutations are the product of multiple mutational and repair processes, some of which are tightly associated with DNA replication. Mutation rates (MR) are known to be higher in late replication timing (RT) regions, but different processes can affect this association. Systematic analysis of the mutational landscape of 2787 tumors from 32 tumor types revealed that approximately one third of the tumor samples show weak association between replication timing and mutation rate. Further analyses revealed that those samples have unique mutational signatures and are enriched with mutations in genes involved in DNA replication, DNA repair and chromatin structure. Surprisingly, analysis of differentially expressed genes between weak and strong RT-MR association groups revealed that tumors with weak association are enriched with genes associated with cell-cell communication and the immune system, suggesting a non-autonomous response to DNA damage.

摘要

癌症体细胞突变是多种突变和修复过程的产物,其中一些过程与 DNA 复制密切相关。众所周知,复制时滞(RT)晚期的突变率(MR)更高,但不同的过程可能会影响这种关联。对来自 32 种肿瘤类型的 2787 个肿瘤的突变景观进行系统分析表明,大约三分之一的肿瘤样本显示 RT 与 MR 之间的弱相关性。进一步的分析表明,这些样本具有独特的突变特征,并富含与 DNA 复制、DNA 修复和染色质结构相关的基因突变。令人惊讶的是,对弱 RT-MR 关联组和强 RT-MR 关联组之间差异表达基因的分析表明,弱关联组的肿瘤富含与细胞间通讯和免疫系统相关的基因,表明对 DNA 损伤的非自主反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d3/10423235/fc88245907aa/41598_2023_39463_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d3/10423235/7c330dc81db3/41598_2023_39463_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d3/10423235/69636a5a89c7/41598_2023_39463_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d3/10423235/33cca8f45c8f/41598_2023_39463_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d3/10423235/096f28a54cd5/41598_2023_39463_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d3/10423235/fc88245907aa/41598_2023_39463_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d3/10423235/7c330dc81db3/41598_2023_39463_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d3/10423235/69636a5a89c7/41598_2023_39463_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d3/10423235/33cca8f45c8f/41598_2023_39463_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d3/10423235/096f28a54cd5/41598_2023_39463_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d3/10423235/fc88245907aa/41598_2023_39463_Fig5_HTML.jpg

相似文献

1
Both cell autonomous and non-autonomous processes modulate the association between replication timing and mutation rate.细胞自主和非自主过程都调节复制时间和突变率之间的关联。
Sci Rep. 2023 Aug 12;13(1):13143. doi: 10.1038/s41598-023-39463-1.
2
Cancer Mutational Processes Vary in Their Association with Replication Timing and Chromatin Accessibility.癌症突变过程在与复制时间和染色质可及性的关联上存在差异。
Cancer Res. 2021 Dec 15;81(24):6106-6116. doi: 10.1158/0008-5472.CAN-21-2039. Epub 2021 Oct 26.
3
Mutational signature SBS8 predominantly arises due to late replication errors in cancer.突变特征 SBS8 主要是由于癌症中晚期的复制错误而产生的。
Commun Biol. 2020 Aug 3;3(1):421. doi: 10.1038/s42003-020-01119-5.
4
Nuclear topology modulates the mutational landscapes of cancer genomes.核拓扑结构调节癌症基因组的突变图谱。
Nat Struct Mol Biol. 2017 Nov;24(11):1000-1006. doi: 10.1038/nsmb.3474. Epub 2017 Oct 2.
5
The clock-like accumulation of germline and somatic mutations can arise from the interplay of DNA damage and repair.遗传和体细胞突变的时钟样积累可能是由 DNA 损伤和修复的相互作用引起的。
PLoS Biol. 2024 Jun 17;22(6):e3002678. doi: 10.1371/journal.pbio.3002678. eCollection 2024 Jun.
6
Replication timing alterations are associated with mutation acquisition during breast and lung cancer evolution.复制时间改变与乳腺癌和肺癌进化过程中的突变获得有关。
Nat Commun. 2024 Jul 18;15(1):6039. doi: 10.1038/s41467-024-50107-4.
7
Cancer mutational burden is shaped by G4 DNA, replication stress and mitochondrial dysfunction.癌症突变负担受 G4 DNA、复制应激和线粒体功能障碍的影响。
Prog Biophys Mol Biol. 2019 Oct;147:47-61. doi: 10.1016/j.pbiomolbio.2019.03.004. Epub 2019 Mar 14.
8
Importance of DNA repair in tumor suppression.DNA修复在肿瘤抑制中的重要性。
Phys Rev E Stat Nonlin Soft Matter Phys. 2004 Dec;70(6 Pt 1):061912. doi: 10.1103/PhysRevE.70.061912. Epub 2004 Dec 22.
9
Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair.癌症基因组中的突变链不对称揭示DNA损伤与修复机制。
Cell. 2016 Jan 28;164(3):538-49. doi: 10.1016/j.cell.2015.12.050. Epub 2016 Jan 21.
10
The interaction between cytosine methylation and processes of DNA replication and repair shape the mutational landscape of cancer genomes.胞嘧啶甲基化与DNA复制及修复过程之间的相互作用塑造了癌症基因组的突变格局。
Nucleic Acids Res. 2017 Jul 27;45(13):7786-7795. doi: 10.1093/nar/gkx463.

本文引用的文献

1
Topography of mutational signatures in human cancer.人类癌症中突变特征的地形。
Cell Rep. 2023 Aug 29;42(8):112930. doi: 10.1016/j.celrep.2023.112930. Epub 2023 Aug 4.
2
Mutational signatures association with replication timing in normal cells reveals similarities and differences with matched cancer tissues.突变特征与正常细胞复制时间的关联揭示了与匹配的癌症组织的相似和不同之处。
Sci Rep. 2023 May 15;13(1):7833. doi: 10.1038/s41598-023-34631-9.
3
Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients.
DNA 修复缺陷型着色性干皮病患者皮肤癌的基因组突变特征。
Nat Commun. 2023 May 4;14(1):2561. doi: 10.1038/s41467-023-38311-0.
4
Exaggerated false positives by popular differential expression methods when analyzing human population samples.分析人类群体样本时,常用差异表达方法会导致假阳性结果夸大。
Genome Biol. 2022 Mar 15;23(1):79. doi: 10.1186/s13059-022-02648-4.
5
Prognostic Value of Neoantigen Load in Immune Checkpoint Inhibitor Therapy for Cancer.肿瘤免疫检查点抑制剂治疗中新生抗原负荷的预后价值。
Front Immunol. 2021 Dec 21;12:689076. doi: 10.3389/fimmu.2021.689076. eCollection 2021.
6
The reactome pathway knowledgebase 2022.反应体通路知识库2022版。
Nucleic Acids Res. 2022 Jan 7;50(D1):D687-D692. doi: 10.1093/nar/gkab1028.
7
Cancer Mutational Processes Vary in Their Association with Replication Timing and Chromatin Accessibility.癌症突变过程在与复制时间和染色质可及性的关联上存在差异。
Cancer Res. 2021 Dec 15;81(24):6106-6116. doi: 10.1158/0008-5472.CAN-21-2039. Epub 2021 Oct 26.
8
The Replication Stress Response on a Narrow Path Between Genomic Instability and Inflammation.基因组不稳定与炎症之间狭窄路径上的复制应激反应
Front Cell Dev Biol. 2021 Jun 25;9:702584. doi: 10.3389/fcell.2021.702584. eCollection 2021.
9
Consequences and Resolution of Transcription-Replication Conflicts.转录-复制冲突的后果与解决
Life (Basel). 2021 Jun 30;11(7):637. doi: 10.3390/life11070637.
10
Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress.靶向治疗 ATR 可使复制应激高的小细胞肺癌产生持久缓解。
Cancer Cell. 2021 Apr 12;39(4):566-579.e7. doi: 10.1016/j.ccell.2021.02.014.